Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders.


Journal

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie
ISSN: 1769-664X
Titre abrégé: Arch Pediatr
Pays: France
ID NLM: 9421356

Informations de publication

Date de publication:
Feb 2020
Historique:
entrez: 17 3 2020
pubmed: 17 3 2020
medline: 23 12 2020
Statut: ppublish

Résumé

Cystic fibrosis (CF) is a channelopathy caused by mutations in the gene encoding the CF transmembrane conductance regulator (CFTR) protein. Diagnosis of CF has long relied on a combination of clinical (including gastrointestinal and/or respiratory) symptoms and elevated sweat chloride concentration. After cloning of the CFTR gene in 1989, genetic analysis progressively became an important aspect of diagnosis. Although combination of sweat test and genetic analysis have simplified the diagnosis of CF in most cases, difficult situations remain, especially in cases that do not fulfill all diagnostic criteria. Such situations are most frequently encountered in patients presenting with a single-organ disease (e.g., congenital absence of the vas deferens, pancreatitis, bronchiectasis) leading to a diagnosis of CFTR-related disorder, or when the presence/ absence of CF is not resolved after newborn screening. This article reviews the diagnostic criteria of CF, with special emphasis on genetic testing. © 2020 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.

Identifiants

pubmed: 32172933
pii: S0929-693X(20)30047-6
doi: 10.1016/S0929-693X(20)30047-6
pii:
doi:

Substances chimiques

CFTR protein, human 0
Cystic Fibrosis Transmembrane Conductance Regulator 126880-72-6

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

eS25-eS29

Informations de copyright

© 2020 Elsevier Masson SAS. Tous droits réservés.

Auteurs

A Pagin (A)

Service de Toxicologie et Génopathies, Institut de Biochimie et Biologie Moléculaire, Centre Hospitalier Régional Universitaire, Lille, France.

I Sermet-Gaudelus (I)

National Reference Center for Cystic Fibrosis, Hôpital Necker, Service de Pneumologie, AP-HP, Paris, France; ERN-Lung CF network; Université de Paris, INSERM U 1016, Institut Cochin, Paris, France.

P-R Burgel (PR)

ERN-Lung CF network; Université de Paris, INSERM U 1016, Institut Cochin, Paris, France; National Reference Center for Cystic Fibrosis, Hôpital Cochin, Service de Pneumologie, AP-HP, Paris, France. Electronic address: pierre-regis.burgel@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH